Immunology and cellular biology of Hodgkin's disease.

Hematol Oncol Clin North Am

Section of Hematology/Oncology, Loyola University Stritch School of Medicine, Maywood, Illinois.

Published: June 1989

Patients with Hodgkin's disease, either untreated or in remission, exhibit a persistent defect in cellular immunity. This cellular immune defect appears to be the result of increased sensitivity to suppressor monocytes and T-suppressor cells, in addition to abnormal Interleukin-2 production. T-lymphocyte function is abnormal in patients with advanced disease. The precise origin of Reed-Sternberg and Hodgkin's cells is unknown. Reed-Sternberg cells function as antigen-presenting cells and as accessory cells in mitogen-induced T-cell proliferation. They have properties in common with dendritic cells and activated lymphocytes. L428 cells express a transformation-associated phosphorylated transmembrane protein, with properties of a growth factor receptor, that may play a role in tumorigenic transformation.

Download full-text PDF

Source

Publication Analysis

Top Keywords

hodgkin's disease
8
cells
7
immunology cellular
4
cellular biology
4
biology hodgkin's
4
disease patients
4
patients hodgkin's
4
disease untreated
4
untreated remission
4
remission exhibit
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!